TABLE 1.
Peptide sequence | Adenylation by MccB in vitro |
In vivo activity |
|
---|---|---|---|
Wild-type cells | ΔyejB cells | ||
MRTGNAN | + | + | − |
MRTGNAD | − | − | − |
MRTGNAQ | − | − | − |
MRAGNAN | −/+ | − | − |
MRLGNAN | +/− | + | − |
MRSGNAN | + | + | − |
MRCGNAN | +/− | + | − |
MRKGNAN | − | − | − |
MR(d-Thr)GNAN | − | − | − |
MRTWNAN | +/− | + | − |
GRTGNAN | − | − | − |
ARTGNAN | − | − | − |
IRTGNAN | +/− | + | − |
VRTGNAN | − | − | − |
LRTGNAN | +/− | + | − |
FRTGNAN | + | + | − |
NRTGNAN | − | − | − |
QRTGNAN | − | − | − |
DRTGNAN | − | − | − |
ERTGNAN | − | − | − |
KRTGNAN | − | − | − |
The table presents the results of in vitro adenylation by MccB of each peptide listed as detected by MALDI-MS analysis of reactions conducted under standard conditions (see, for example, Fig. 2 and Materials and Methods) and the results of bioactivity testing of 10-μl aliquots of products of completed adenylation reactions on lawns of wild-type or yejB mutant E. coli cell lawns. +, a clear growth inhibition zone was detected; −, no growth inhibition zone was observed; +/−, incomplete conversion.